免疫療法和細胞工程市場：按細胞類型、產品類型、疾病、應用、最終用戶和地區分類

預計到2026年，免疫療法市場規模將達到51.9億美元，到2033年將達到217.3億美元。預計從2026年到2033年，該市場將以22.7%的複合年成長率成長。

近年來，免疫療法因其有望徹底改變包括癌症在內的多種疾病的治療方式而備受關注。該領域透過操控和改造免疫細胞，增強其靶向並摧毀癌細胞和其他病原體的能力。這個新興領域融合了免疫學、分子生物學和基因工程的原理，致力於開發創新療法。

免疫系統在識別和清除體內外來入侵者和異常細胞方面發揮著至關重要的作用。然而，在某些情況下，免疫反應可能不足以對抗某些疾病，甚至無效。透過基因改造免疫細胞，科學家可以增強其識別和攻擊特定標靶（例如癌細胞）的能力。

市場動態：

免疫療法市場受幾個關鍵因素驅動。首先，包括癌症、自體免疫疾病和感染疾病的多種疾病的發生率正在上升。傳統的治療方法往往有局限性，因此需要創新的治療方法。

其次，基因編輯技術的進步顯著提高了免疫療法的效率和精準度。諸如CRISPR/Cas9之類的基因編輯工具使得改造免疫細胞並增強其治療潛力變得更加容易。這些技術創新有望推動免疫療法市場的成長。

然而，仍有許多挑戰和限制。其中一個主要挑戰是免疫療法的高成本。這些療法的研發和生產過程複雜，需要專門的設施和專業技術。因此，獲得這些療法的機會有限，尤其是在開發中國家。

例如，2022年12月，製藥公司吉利德科學宣布收購臨床階段生物技術公司Tmunity Therapeutics。此次收購使吉利德科學獲得了臨床前和臨床項目，其中包括一個「強化型」CAR-T細胞技術平台，該平台應用於各種CAR-T細胞時，有望增強其抗腫瘤活性，並將有助於改進CAR-T細胞產品的生產過程。

本研究的主要特點：

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數介紹了全球免疫療法市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
• 這份「全球免疫療法市場」報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用全球免疫療法市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景

第4章：免疫療法市場：依細胞類型分類，2021-2033年

• T細胞
• NK細胞
• 樹突狀細胞
• 癌細胞
• 幹細胞
• 其他

第5章 免疫細胞工程市場：依產品分類，2021-2033年

• 消耗品
• 裝置
• 軟體

第6章：免疫療法市場：依疾病適應症分類，2021-2033年

• 心血管疾病
• 呼吸系統疾病
• 感染疾病
• 癌症
• 神經系統疾病
• 其他

第7章 免疫細胞工程市場：依應用領域分類，2021-2033年

• 出於研究目的
• 細胞療法和再生醫學
• 其他

第8章 免疫療法市場：依最終用戶分類，2021-2033年

• 製藥和生物技術公司
• 醫院和診所
• 學術研究機構
• 細胞庫
• 其他

第9章 免疫細胞工程市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Danaher Corporation
• Lonza
• Miltenyi Biotec
• Takara Bio Inc.
• Sartoroius CellGenix GmbH
• FUJIFILM Irvine Scientific
• Agilent Technologies, Inc.
• Bio-Techne
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company
• Charles River Laboratories
• Creative Bioarray
• Sartorius AG
• Novogene Co, Ltd.
• AGC Biologics
• Catalent, Inc
• WuXi AppTec
• Discovery Life Sciences

第11章

• 調查方法
• 關於本公司

Immune Cell Engineering Market is estimated to be valued at USD 5.19 Bn in 2026 and is expected to reach USD 21.73 Bn by 2033, growing at a compound annual growth rate (CAGR) of 22.7% from 2026 to 2033.

Immune cell engineering is a field that has gained significant attention in recent years due to its potential to revolutionize the treatment of various diseases, including cancer. It involves the manipulation and modification of immune cells to enhance their ability to target and destroy cancer cells or other pathogens. This emerging field combines principles of immunology, molecular biology, and genetic engineering to develop innovative therapies.

The immune system plays a critical role in recognizing and eliminating foreign invaders or abnormal cells in the body. However, in some cases, the immune response may be insufficient or ineffective against certain diseases. By genetically modifying immune cells, scientists can enhance their ability to recognize and attack specific targets, such as cancer cells.

Market Dynamics:

The immune cell engineering market is driven by several key factors. Firstly, there is a growing prevalence of various diseases, including cancer, autoimmune disorders, and infectious diseases. As traditional treatment options for these diseases often have limitations, there is a need for innovative therapeutic approaches.

Secondly, advancements in gene-editing technologies have significantly improved the efficiency and precision of immune cell engineering. Gene-editing tools such as CRISPR/Cas9 have made it easier to modify immune cells and enhance their therapeutic potential. These technological innovations are expected to drive the growth of the immune cell engineering market.

However, there are also several challenges and restraints that need to be addressed. One of the main challenges is the high cost associated with immune cell engineering therapies. The development and manufacturing processes for these therapies are complex and require specialized facilities and expertise. This has limited the accessibility of these therapies, particularly in developing countries.

For instance, in December 2022, Gilead Sciences, Inc., a pharmaceutical company, announced the acquisition of Tmunity Therapeutics Inc., a clinical-stage biotechnology company. The acquisition provided Gilead Sciences, Inc. with preclinical and clinical programs, including an "armored" CAR T technology platform that has the potential to be applied to a variety of CAR T cells to enhance anti-tumor activity, and helps to enhance manufacturing processes for of CAR T cells product.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global immune cell engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza, Miltenyi Biotec, Takara Bio Inc., Sartoroius CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technologies, Inc., Bio-Techne, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Charles River Laboratories, Creative Bioarray, Sartorius AG, Novogene Co, Ltd., AGC Biologics, Catalent, Inc., WuXi AppTec, Discovery Life Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global immune cell engineering market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immune cell engineering market

Detailed Segmentation:

• Global Immune Cell Engineering Market, By Cell Type
• T Cells
• NK Cells
• Dendritic Cells
• Tumor Cells
• Stem Cells
• Others
• Global Immune Cell Engineering Market, By Product
• Consumables
• Instruments
• Software
• Global Immune Cell Engineering Market, By Disease Indication
• Cardiovascular Diseases
• Respiratory Diseases
• Infectious Diseases
• Cancer
• Neurological Diseases
• Others
• Global Immune Cell Engineering Market, By Application
• Research Applications
• Cell Therapy & Regenerative Medicine
• Others
• Global Immune Cell Engineering Market, By End User
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Academic & Research Institutes
• Cell Banks
• Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Top companies in Immune Cell Engineering Market:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Danaher Corporation
• Lonza
• Miltenyi Biotec
• Takara Bio Inc.
• Sartoroius CellGenix GmbH
• FUJIFILM Irvine Scientific
• Agilent Technologies, Inc.
• Bio-Techne
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company
• Charles River Laboratories
• Creative Bioarray
• Sartorius AG
• Novogene Co, Ltd.
• AGC Biologics
• Catalent, Inc
• WuXi AppTec
• Discovery Life Sciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Immune Cell Engineering Market, By Cell Type
  • Market Immune Cell Engineering Market, By Product
  • Market Immune Cell Engineering Market, By Disease Indication
  • Market Immune Cell Engineering Market, By Application
  • Market Immune Cell Engineering Market, By End User
  • Market Immune Cell Engineering Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Immune Cell Engineering Market , By Cell Type, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• T Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• NK Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Dendritic Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Tumor Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Immune Cell Engineering Market , By Product, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Immune Cell Engineering Market , By Disease Indication, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Respiratory Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Neurological Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Immune Cell Engineering Market , By Application, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Research Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Cell Therapy & Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Immune Cell Engineering Market , By End User, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Cell Banks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Immune Cell Engineering Market , By Region, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country 2022 -2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • Germany
    • U..K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Thermo Fisher Scientific,Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lonza
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Miltenyi Biotec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Takara Bio Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sartoroius CellGenix GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• FUJIFILM Irvine Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agilent Technologies,Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Techne
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Bioarray
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sartorius AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novogene Co, Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AGC Biologics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Catalent, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• WuXi AppTec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Discovery Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us